Paclitaxel, Carboplatin, and Oral Etoposide Followed by Weekly Paclitaxel in High Grade Neuroendocrine Carcinoma
This study has been completed.
Sponsor:
Sarah Cannon Research Institute
Collaborator:
Bristol-Myers Squibb
Information provided by:
Sarah Cannon Research Institute
ClinicalTrials.gov Identifier:
NCT00193531
First received: September 12, 2005
Last updated: June 28, 2010
Last verified: October 2008
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | January 2007 |
| Primary Completion Date: | January 2007 (Final data collection date for primary outcome measure) |